The utility of procalcitonin as a biomarker of hospitalacquired infection in severe COVID19

Simple item page
dc.article.end-page175en
dc.article.start-page170en
dc.citation.doi10.7196/AJTCCM.2024.V30I4.1617en
dc.contributor.authorC Schmidten
dc.contributor.authorPeter Nyasuluen
dc.contributor.authorI Fwembaen
dc.contributor.authorU Lallaen
dc.contributor.authorB. W Allwooden
dc.contributor.authorE et alen
dc.date.accessioned2025-03-06T17:26:44Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationSCOPUSen
dc.identifier.issn26170191en
dc.identifier.urihttps://hdl.handle.net/10539/44110
dc.journal.titleThe utility of procalcitonin as a biomarker of hospitalacquired infection in severe COVID19en
dc.journal.volume30en
dc.titleThe utility of procalcitonin as a biomarker of hospitalacquired infection in severe COVID19en
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
463.67 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)